Skip to content

â??Developing and Validating a new instrument or scale to measure fatigue among Cancer Patientsâ??. The study procedure includes completing a demographic proforma and self-reported questionnaire by the cancer patients on fatigue at one time.

Development and Validation of an Integrated Fatigue Scale.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/10/046778
Enrollment
950
Registered
2022-10-26
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D099- Carcinoma in situ, unspecified Health Condition 2: D00-D09- In situ neoplasms

Interventions

None listed

Sponsors

Holy Cross Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cancer patients 1.Who are between 18 to 65 years 2.Who are able to read and write English, Kannada or Malayalam 3. Who are informed of their cancer diagnosis and undergoing/undergone treatment

Exclusion criteria

Exclusion criteria: Cancer patients 1.Who are suffering from severe mental or cognitive disorders 2. Who are referred to palliative care services for end of life care

Design outcomes

Primary

MeasureTime frame
The development of an Integrated Fatigue Scale for cancer patients. This newly developed integrated fatigue scale will be brief and easy to administer and patient friendly. It will measure fatigue based on the self-reported symptoms of cancer patients and will help in treating the cancer patients in time and can enhance their quality of life.Timepoint: eight weeks time

Secondary

MeasureTime frame
A newly developed and validated integrated fatigue scale will be available for public for research use.Timepoint: From 2024 October on wards;Development and Validation of an Integrated Fatigue Scale to measure fatigue in cancer patients.Timepoint: outcome will be assessed only once at baseline. Cross sectional study.

Countries

India

Contacts

Public ContactDr Sr Doris Mookanamparambil

Nitte Usha Institute of Nursing Sciences (Nitte University)

sabitha@nitte.edu.in9448842698

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026